More on NRSN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (6.7 Score)

Upcoming Events

- Earnings (12/2/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Neurosense Therapeutics (NQ:NRSN)
Delayed: 2.33 -0.13 (5.28%)
Prev. Close $2.46  
Open$2.47 
52 Wk High$ 
52 Wk Low$ 
Day High$2.75 
Day Low$2.31 
P/E N/A  
EPS$ 
Volume29,710 

Friends, Peers and Foes (?): NRSNW H1Z (more...)

Oct 26, 2026 12:45 PM Form 6-K NeuroSense Therapeutics For: Oct 26
Oct 19, 2026 09:48 AM Form 6-K NeuroSense Therapeutics For: Oct 19
Oct 19, 2026 08:28 AM NeuroSense files U.S. patent for PrimeC in traumatic brain injury
Oct 19, 2026 08:25 AM NeuroSense Files U.S. Patent Application for Traumatic Brain Injury
Oct 13, 2026 08:41 AM Form 6-K NeuroSense Therapeutics For: Oct 13
Oct 13, 2026 08:31 AM NeuroSense schedules Nasdaq hearing for November amid listing issues
Oct 13, 2026 08:30 AM NeuroSense Secures Nasdaq Hearing Date as PrimeC Approaches Key Regulatory and Funding Milestones
Oct 12, 2026 04:37 PM Roth/MKM Downgrades NeuroSense Therapeutics Ltd. (NRSN) to Neutral
Oct 2, 2026 04:20 PM NeuroSense faces Nasdaq delisting risk over market value rule
Oct 2, 2026 04:15 PM Form 6-K NeuroSense Therapeutics For: Oct 02
View All Articles

Entities mentioned with NRSN

View All Entities